Tumor localization using fluorescence has been made practical by curre
nt improvements in tumor targeting molecules, especially monoclonal an
tibodies and their derivatives, by the development of convenient near-
infrared emitting fluorochromes and by the availability of digital cam
eras having high sensitivity in this spectral region. Recent studies i
n animals have demonstrated that fluorochrome labeling of monoclonal a
ntibodies confers adequate sensitivity and improved resolution. Distri
bution and catabolism of fluorochrome-labeled and radiolabeled antibod
ies are similar. Simultaneous localization of multiple reagents is mad
e possible by labeling with several different near-infrared emitting f
luorochromes; thus background subtraction and differential labeling of
multiple tumor-associated components can be performed. Difficulties i
n using the fluorochrome labels are mainly related to light scattering
and absorption in tissues, but detection of small tumors at depths of
several millimeters is feasible. The major medical use of this new te
chnology is likely to be endoscopic location of tumors. Scientific use
s include studies of tumor metastasis, uptake and distribution of drug
s and tumor-targeting molecules by tumors, and migration patterns of n
ear-infrared labeled cells in vivo.